Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog Lu-177-DOTA-PP-F11N: Does the Use of Protease Inhibitors Further Improve In Vivo Distribution?

Sauter, Alexander W.; Mansi, Rosalba; Hassiepen, Ulrich; Muller, Lionel; Panigada, Tania; Wiehr, Stefan; Wild, Anna-Maria; Geistlich, Susanne; Behe, Martin; Rottenburger, Christof; Wild, Damian; Fani, Melpomeni

dc.contributor.author	Sauter, Alexander Walter
dc.contributor.author	Wiehr, Stefan
dc.contributor.author	Wild, Anna-Maria
dc.date.accessioned	2020-05-28T12:12:34Z
dc.date.available	2020-05-28T12:12:34Z
dc.date.issued	2019
dc.identifier.issn	1535-5667
dc.identifier.uri	http://hdl.handle.net/10900/101043
dc.language.iso	en	de_DE
dc.publisher	Soc Nuclear Medicine Inc	de_DE
dc.relation.uri	http://dx.doi.org/10.2967/jnumed.118.207845	de_DE
dc.subject.ddc	610	de_DE
dc.title	Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog Lu-177-DOTA-PP-F11N: Does the Use of Protease Inhibitors Further Improve In Vivo Distribution?	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190926111821_02387
utue.publikation.seiten	393-399	de_DE
utue.personen.roh	Sauter, Alexander W.
utue.personen.roh	Mansi, Rosalba
utue.personen.roh	Hassiepen, Ulrich
utue.personen.roh	Muller, Lionel
utue.personen.roh	Panigada, Tania
utue.personen.roh	Wiehr, Stefan
utue.personen.roh	Wild, Anna-Maria
utue.personen.roh	Geistlich, Susanne
utue.personen.roh	Behe, Martin
utue.personen.roh	Rottenburger, Christof
utue.personen.roh	Wild, Damian
utue.personen.roh	Fani, Melpomeni
dcterms.isPartOf.ZSTitelID	Journal of Nuclear Medicine	de_DE
dcterms.isPartOf.ZS-Issue	3	de_DE
dcterms.isPartOf.ZS-Volume	60	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE